{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:42:21Z","timestamp":1773783741877,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.yexmp.2007.08.012","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T11:18:08Z","timestamp":1189250288000},"page":"471-473","source":"Crossref","is-referenced-by-count":43,"title":["Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias"],"prefix":"10.1016","volume":"83","author":[{"given":"Jeanann L.","family":"Suggs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius M.","family":"Cruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yexmp.2007.08.012_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/138920106778521578","article-title":"Monoclonal antibodies for the treatment of acute myeloid leukemia","volume":"7","author":"Abutalib","year":"2006","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"11","key":"10.1016\/j.yexmp.2007.08.012_bib2","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1080\/10428190600821989","article-title":"Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia","volume":"47","author":"Herrera","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.yexmp.2007.08.012_bib3","series-title":"World Health Organization classification of tumours","year":"2001"},{"issue":"2","key":"10.1016\/j.yexmp.2007.08.012_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yexmp.2006.06.006","article-title":"The immunophenotype of pre-TALL\/LBL revisited","volume":"81","author":"Lewis","year":"2006","journal-title":"Exp. Mol. Pathol."},{"issue":"3","key":"10.1016\/j.yexmp.2007.08.012_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14712598.7.3.319","article-title":"Monoclonal antibody-based therapeutics for leukemia","volume":"7","author":"Li","year":"2007","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480007001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480007001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T07:52:19Z","timestamp":1546588339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480007001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0014480007001098"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2007.08.012","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}